Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

10. Dezember 2014 07:00 ET | Quelle: Immunovaccine Inc.

Immunovaccine Receives FDA Fast Track Designation for DPX-Survivac for Treatment of Ovarian Cancer

HALIFAX, NOVA SCOTIA--(Marketwired - Dec. 10, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX:IMV), a clinical stage vaccine and immunotherapy company, today announced that...
24. November 2014 17:23 ET | Quelle: Immunovaccine Inc.

Immunovaccine Receives Final Approval to Graduate to TSX

HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 24, 2014) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy company, today...
19. November 2014 08:05 ET | Quelle: Immunovaccine Inc.

Health Canada Clears Immunovaccine to Conduct Phase II Clinical Trial of DPX-Survivac in Recurrent Lymphoma

HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 19, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy company, today announced...
14. November 2014 16:39 ET | Quelle: Immunovaccine Inc.

Immunovaccine Announces Financial Results for Quarter Ended September 30, 2014

HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 14, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine company, today released its financial and...
12. November 2014 08:05 ET | Quelle: Immunovaccine Inc.

Immunovaccine Receives Conditional Approval to Graduate to Toronto Stock Exchange (TSX)

HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 12, 2014) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy company, today...
21. Oktober 2014 08:05 ET | Quelle: Immunovaccine Inc.

Immunovaccine Demonstrates Protection Against Lethal Anthrax Challenge With Rapid Acting, Single Dose Vaccine

HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 21, 2014) - Immunovaccine Inc. ("Immunovaccine") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy company, today announced positive...
06. Oktober 2014 08:05 ET | Quelle: Immunovaccine Inc.

Immunovaccine to Provide Update on Ongoing Ebola Virus and Cancer Vaccine Programs at 13th Annual BIO Investor Forum

HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 6, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV" or "the Company") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy company,...
06. Oktober 2014 08:00 ET | Quelle: Immunovaccine Inc.

Immunovaccine Announces Changes to Stock Option Plan

HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 6, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV" or "the Company") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy company,...
01. Oktober 2014 08:05 ET | Quelle: Immunovaccine Inc.

Immunovaccine Announces Plans for Phase II Clinical Trial of DPX-Survivac in Patients with Recurrent Lymphoma

HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 1, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy company, today provided a...
26. September 2014 08:05 ET | Quelle: Immunovaccine Inc.

Immunovaccine Adds Broad Business Operations and Capital Raising Expertise to Board of Directors with New Appointments

HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 26, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV" or "the Company") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy...

Vorherige Seite

Nächste Seite